Elisa Act Laboratories manufactures the http elisa act act reagents distributed by Genprice. The Http Elisa Act Act reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact elisa act. Other Http products are available in stock. Specificity: Http Category: Elisa Group: Act Act
Bovine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Bovine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Canine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Canine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Canine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Canine PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Chicken PSA-ACT (PSA-ACT) ELISA Kit |
MyBiosource |
INQUIRE |
Ask for price |
Act Act information
ACT-660602 |
HY-151096 |
MedChemExpress |
10 mg |
EUR 2759.78 |
Description: ACT-660602 is an orally active antagonist of chemokine receptor (CXCR3) with an IC50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases research[1][2]. |
ACT-672125 |
HY-153240 |
MedChemExpress |
Get quote |
Ask for price |
Description: ACT-672125 is a potent CXCR3 antagonist with IC50 value of 239 nM in human blood. ACT-672125 has activity for hERG with IC50 value of 18μM. ACT-672125 can be used for the research of autoimmune diseases[1]. |
ACT-373898 |
HY-135500 |
MedChemExpress |
10mg |
Ask for price |
Description: ACT-373898 is an inactive carboxylic acid metabolite of Macitentan. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist[1]. |
ACT-462206 |
HY-101834 |
MedChemExpress |
10 mg |
EUR 616.89 |
Description: ACT-462206 is an orally active and potent dual Orexin 1/Orexin 2 receptor antagonist with IC50s of 60 nM (Orexin 1) and 11 nM (Orexin 2), respectively. ACT-462206 exhibits brain penetration properties, and can be used for insomnia, stress/anxiety-related disorders and addiction research[1]. |
ACT-335827 |
HY-108683 |
MedChemExpress |
5 mg |
EUR 790.06 |
Description: ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders[1]. |
ACT-451840 |
HY-111817 |
MedChemExpress |
10 mg |
EUR 1461.06 |
Description: ACT-451840 is an orally active, potent and low-toxicity compound, showing activity against sensitive and resistant plasmodium falciparum strains. ACT-451840 targets all asexual blood stages of the parasite, has a rapid onset of action. ACT-451840 behaves in a way similar to artemisinin derivatives, with very rapid onset of action and elimination of parasite. ACT-451840 can be used for the research of malarial[1][2][3]. |
ACT-209905 |
HY-12616 |
MedChemExpress |
Get quote |
Ask for price |
Description: ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 also has immunomodulating activity, and can be used in research of autoimmune diseases[1]. |
ACT-389949 |
HY-124071 |
MedChemExpress |
1 mg |
EUR 1785.74 |
Description: ACT-389949 is a first-in-class, potent and selective and agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes. ACT-389949 has potential for the treatment of inflammatory disorders[1][2]. |
ACT-777991 |
HY-149055 |
MedChemExpress |
Get quote |
Ask for price |
Description: ACT-777991 is an orally active and selective CXCR3 antagonist. ACT-777991 has microsomes and hepatocytes stability across animal models. ACT-777991 inhibits the migration of activated T cells toward CXCL11[1]. |
ACT-606559 |
HY-141621 |
MedChemExpress |
Get quote |
Ask for price |
Description: ACT-606559, a new chemical entity with antimalarial activity, is a metabolite of ACT451840. ACT-606559 can be used for the research of malarial[1]. |
ACT-335827 |
MBS3840044-5x50mg |
MyBiosource |
5x50mg |
EUR 2845 |